This report was published by WHO Regional Office for the Eastern Mediterranean Region in 2009. The report presents the results of transparency assessments in the hope of providing a comprehensive picture of the level of transparency and the potential vulnerability to corruption of six essential functions of the public pharmaceutical sector – registration, promotion, inspection, selection, procurement and distribution of medicines. Two national investigators nominated from the Jordan Food and Drug Administration (JFDA) and from the Ministry of Health (national assessor plus co‐assessor) collected data by conducting a series of interviews with carefully selected key informants. The report provides qualitative and quantitative information.